These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37023372)

  • 1. Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia.
    Jiang Q; Stachelscheid J; Bloehdorn J; Pacholewska A; Aszyk C; Grotenhuijs F; Müller T; Onder O; Wagle P; Herling CD; Kleppe M; Wang Z; Coombes KR; Robrecht S; Dalvi PS; Plosnita B; Mayer P; Abruzzo LV; Altmüller J; Gathof B; Persigehl T; Fischer K; Jebaraj B; Rienhoff HY; Ecker R; Zhao Y; Bruns CJ; Stilgenbauer S; Elenitoba-Johnson K; Hallek M; Schweiger MR; Odenthal M; Vasyutina E; Herling M
    Blood; 2023 Jul; 142(1):44-61. PubMed ID: 37023372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM1A microenvironment, its oncogenic potential, and therapeutic significance.
    Ismail T; Lee HK; Kim C; Kwon T; Park TJ; Lee HS
    Epigenetics Chromatin; 2018 Jun; 11(1):33. PubMed ID: 29921310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
    Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
    Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.
    Pajtler KW; Weingarten C; Thor T; Künkele A; Heukamp LC; Büttner R; Suzuki T; Miyata N; Grotzer M; Rieb A; Sprüssel A; Eggert A; Schramm A; Schulte JH
    Acta Neuropathol Commun; 2013 May; 1():19. PubMed ID: 24252778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of KDM1A suppresses tumour migration and invasion by epigenetically regulating the TIMP1/MMP9 pathway in papillary thyroid cancer.
    Zhang W; Sun W; Qin Y; Wu C; He L; Zhang T; Shao L; Zhang H; Zhang P
    J Cell Mol Med; 2019 Aug; 23(8):4933-4944. PubMed ID: 31211500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL.
    Stachelscheid J; Jiang Q; Aszyk C; Warner K; Bley N; Müller T; Vydzhak O; Symeonidis K; Crispatzu G; Mayer P; Blakemore SJ; Goehring G; Newrzela S; Hippler S; Robrecht S; Kreuzer KA; Pallasch C; Krüger M; Lechner A; Fischer K; Stilgenbauer S; Beutner D; Hallek M; Auguin D; Hüttelmaier S; Bloehdorn J; Vasyutina E; Herling M
    Blood; 2023 Mar; 141(12):1425-1441. PubMed ID: 36179280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay between the lysine demethylase KDM1A and DNA methyltransferases in cancer cells is cell cycle dependent.
    Brenner C; Luciani J; Bizet M; Ndlovu M; Josseaux E; Dedeurwaerder S; Calonne E; Putmans P; Cartron PF; Defrance M; Fuks F; Deplus R
    Oncotarget; 2016 Sep; 7(37):58939-58952. PubMed ID: 27449289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes.
    McGrath JP; Williamson KE; Balasubramanian S; Odate S; Arora S; Hatton C; Edwards TM; O'Brien T; Magnuson S; Stokoe D; Daniels DL; Bryant BM; Trojer P
    Cancer Res; 2016 Apr; 76(7):1975-88. PubMed ID: 26837761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline Lysine-Specific Demethylase 1 (
    Wei X; Calvo-Vidal MN; Chen S; Wu G; Revuelta MV; Sun J; Zhang J; Walsh MF; Nichols KE; Joseph V; Snyder C; Vachon CM; McKay JD; Wang SP; Jayabalan DS; Jacobs LM; Becirovic D; Waller RG; Artomov M; Viale A; Patel J; Phillip J; Chen-Kiang S; Curtin K; Salama M; Atanackovic D; Niesvizky R; Landgren O; Slager SL; Godley LA; Churpek J; Garber JE; Anderson KC; Daly MJ; Roeder RG; Dumontet C; Lynch HT; Mullighan CG; Camp NJ; Offit K; Klein RJ; Yu H; Cerchietti L; Lipkin SM
    Cancer Res; 2018 May; 78(10):2747-2759. PubMed ID: 29559475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells.
    Harris WJ; Huang X; Lynch JT; Spencer GJ; Hitchin JR; Li Y; Ciceri F; Blaser JG; Greystoke BF; Jordan AM; Miller CJ; Ogilvie DJ; Somervaille TC
    Cancer Cell; 2012 Apr; 21(4):473-87. PubMed ID: 22464800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysine demethylase KDM1A promotes cell growth via FKBP8-BCL2 axis in hepatocellular carcinoma.
    Lv S; Zhao X; Zhang E; Yan Y; Ma X; Li N; Zou Q; Sun L; Song T
    J Biol Chem; 2022 Sep; 298(9):102374. PubMed ID: 35970393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sperm histone H3 lysine 4 trimethylation is altered in a genetic mouse model of transgenerational epigenetic inheritance.
    Lismer A; Siklenka K; Lafleur C; Dumeaux V; Kimmins S
    Nucleic Acids Res; 2020 Nov; 48(20):11380-11393. PubMed ID: 33068438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
    Hofbauer SW; Piñón JD; Brachtl G; Haginger L; Wang W; Jöhrer K; Tinhofer I; Hartmann TN; Greil R
    Cancer Res; 2010 Sep; 70(18):7336-44. PubMed ID: 20823161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Function of histone demethylasehistone lysine-specific demethylase 1A in tumor initiation and progression].
    Zhang X; An X; Zhu S; Liu Y
    Sheng Wu Gong Cheng Xue Bao; 2020 Feb; 36(2):226-240. PubMed ID: 32147995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprobe-based assays of histone lysine demethylase 1A target occupation enable
    Mascaró C; Ortega A; Carceller E; Ruiz Rodriguez R; Ciceri F; Lunardi S; Yu L; Hilbert M; Maes T
    J Biol Chem; 2019 May; 294(20):8311-8322. PubMed ID: 30804215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D.
    Wang Y; Cao K
    J Immunol Res; 2021; 2021():9965099. PubMed ID: 34307695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia.
    Maes T; Mascaró C; Tirapu I; Estiarte A; Ciceri F; Lunardi S; Guibourt N; Perdones A; Lufino MMP; Somervaille TCP; Wiseman DH; Duy C; Melnick A; Willekens C; Ortega A; Martinell M; Valls N; Kurz G; Fyfe M; Castro-Palomino JC; Buesa C
    Cancer Cell; 2018 Mar; 33(3):495-511.e12. PubMed ID: 29502954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KDM1A and KDM3A promote tumor growth by upregulating cell cycle-associated genes in pancreatic cancer.
    Hou X; Li Q; Yang L; Yang Z; He J; Li Q; Li D
    Exp Biol Med (Maywood); 2021 Sep; 246(17):1869-1883. PubMed ID: 34171978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia.
    Boncompagni G; Tatangelo V; Lopresti L; Ulivieri C; Capitani N; Tangredi C; Finetti F; Marotta G; Frezzato F; Visentin A; Ciofini S; Gozzetti A; Bocchia M; Calzada-Fraile D; Martin Cofreces NB; Trentin L; Patrussi L; Baldari CT
    Cell Death Dis; 2024 Feb; 15(2):144. PubMed ID: 38360867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aging alters histone H3 lysine 4 methylation in mouse germinal vesicle stage oocytes.
    Shao GB; Wang J; Zhang LP; Wu CY; Jin J; Sang JR; Lu HY; Gong AH; Du FY; Peng WX
    Reprod Fertil Dev; 2015 Jan; 27(2):419-26. PubMed ID: 24384042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.